| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| systematic review | Q1504425 |
| review article | Q7318358 |
| P50 | author | John Osei Sekyere | Q57858414 |
| P2860 | cites work | In Vitro Activity of a Novel Glucan Synthase Inhibitor, SCY-078, against Clinical Isolates of Candida auris. | Q53789385 |
| First reported case of multidrug-resistant Candida auris in Canada. | Q55017741 | ||
| First report of Candida auris in Oman: Clinical and microbiological description of five candidemia cases | Q88232114 | ||
| Identification of Candida haemulonii Complex Species: Use of ClinProTools(TM) to Overcome Limitations of the Bruker Biotyper(TM), VITEK MS(TM) IVD, and VITEK MS(TM) RUO Databases | Q39033046 | ||
| Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values. | Q39092102 | ||
| Donor-derived transmission of Candida auris during lung transplantation | Q39092106 | ||
| Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins. | Q39092125 | ||
| First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia | Q39092138 | ||
| Incidence, characteristics and outcome of ICU-acquired candidemia in India | Q39092143 | ||
| Multidrug-resistant endemic clonal strain of Candida auris in India. | Q39092162 | ||
| Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris | Q39092215 | ||
| Simple low cost differentiation of Candida auris from Candida haemulonii complex using CHROMagar Candida medium supplemented with Pal's medium | Q39092219 | ||
| Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis | Q39092224 | ||
| Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection | Q39092240 | ||
| The first cases of Candida auris candidaemia in Oman | Q39092264 | ||
| Environmental Surfaces in Healthcare Facilities are a Potential Source for Transmission of Candida auris and Other Candida Species | Q39092300 | ||
| Nosocomial fungemia by Candida auris: First four reported cases in continental Europe. | Q39092317 | ||
| Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation | Q39092330 | ||
| Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris. | Q39092336 | ||
| Clinical Alert: Candida Auris | Q39092350 | ||
| Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities - United States, June 2016-May 2017. | Q39092357 | ||
| Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus - United States, May 2013-August 2016. | Q39092367 | ||
| UN High-Level Meeting on antimicrobials--what do we need? | Q40593042 | ||
| A Pilot Study on Carbapenemase Detection: Do We See the Same Level of Agreement as with the CLSI Observations | Q41071782 | ||
| Emergence of Klebsiella pneumoniae co-producing NDM-1, OXA-48, CTX-M-15, CMY-16, QnrA and ArmA in Switzerland | Q42201822 | ||
| Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories? | Q42326663 | ||
| Candida auris-associated candidemia, South Africa | Q42712931 | ||
| Rapid Detection of Polymyxin Resistance in Enterobacteriaceae | Q42762418 | ||
| Candida auris candidemia in Kuwait, 2014. | Q42787996 | ||
| Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features | Q43521723 | ||
| Candidemia caused by amphotericin B and fluconazole resistant Candida auris | Q44304263 | ||
| Current State of Resistance to Antibiotics of Last-Resort in South Africa: A Review from a Public Health Perspective | Q28069348 | ||
| Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia | Q28818814 | ||
| Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species | Q28829671 | ||
| Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts | Q30561825 | ||
| Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections | Q30888780 | ||
| Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital | Q33401940 | ||
| Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. | Q33609053 | ||
| Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally | Q33704302 | ||
| Current perspective on emergence, diagnosis and drug resistance in Candida auris | Q33812143 | ||
| Use of RNA-Protein Complexes for Genome Editing in Non-albicans Candida Species | Q33823090 | ||
| First three reported cases of nosocomial fungemia caused by Candida auris | Q34196357 | ||
| New clonal strain of Candida auris, Delhi, India | Q34372060 | ||
| Draft Genome Sequence of a Fluconazole-Resistant Candida auris Strain from a Candidemia Patient in India | Q34485537 | ||
| Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris | Q34492906 | ||
| First hospital outbreak of the globally emerging Candida auris in a European hospital | Q34543358 | ||
| Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses | Q34547546 | ||
| Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek | Q35586995 | ||
| Review of established and innovative detection methods for carbapenemase-producing Gram-negative bacteria. | Q35739471 | ||
| Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism. | Q35835357 | ||
| Detection of amphotericin B resistance in Candida haemulonii and closely related species by use of the Etest, Vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methods | Q36022880 | ||
| Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry | Q36049838 | ||
| Identification of Uncommon Candida Species Using Commercial Identification Systems | Q36155872 | ||
| Matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) for rapid identification of micro-organisms in the routine clinical microbiology laboratory | Q36227115 | ||
| Genomic and phenotypic characterisation of fluoroquinolone resistance mechanisms in Enterobacteriaceae in Durban, South Africa | Q36411319 | ||
| Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel | Q37664411 | ||
| Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge | Q38173058 | ||
| Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Healthcare Surface | Q38659451 | ||
| Colistin and tigecycline resistance in carbapenemase-producing Gram-negative bacteria: emerging resistance mechanisms and detection methods | Q38827769 | ||
| Candida auris candidaemia in Indian ICUs: analysis of risk factors | Q38883902 | ||
| The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. | Q38949297 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Candida | Q131260 |
| antifungal | Q578726 | ||
| Candida auris | Q26816853 | ||
| candidemia | Q54946225 | ||
| fungal multiple drug resistance | Q70695790 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P577 | publication date | 2018-01-18 | |
| 2018-08-01 | |||
| P1433 | published in | MicrobiologyOpen | Q27724394 |
| P1476 | title | Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. |
| Q58090050 | Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens |
| Q89510130 | Candida auris, an Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind? |
| Q89944189 | Candida auris: A Decade of Understanding of an Enigmatic Pathogenic Yeast |
| Q91643627 | Candida auris: A Review of Recommendations for Detection and Control in Healthcare Settings |
| Q92610025 | Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen |
| Q95642098 | Candida auris: From Multidrug Resistance to Pan-Resistant Strains |
| Q91693316 | Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria |
| Q92082086 | Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens |
| Q58598193 | Epidemiology, clinical characteristics, resistance, and treatment of infections by |
| Q57294706 | Evaluation of a new matrix-assisted laser desorption/ionization time-of-flight mass spectrometry system for the identification of yeast isolation |
| Q93104959 | Experimental Mouse Models of Disseminated Candida auris Infection |
| Q89355063 | From hidden outbreaks to epidemic emergencies: the threat associated with neglecting emerging pathogens |
| Q96155834 | Genetic Heterogeneity of Australian Candida auris Isolates: Insights From a Nonoutbreak Setting Using Whole-Genome Sequencing |
| Q92039317 | In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris |
| Q104135019 | In vitro synergy of isavuconazole in combination with colistin against Candida auris |
| Q92142505 | Isolation of Candida auris from cystic fibrosis patient, Greece, April 2019 |
| Q98936603 | Management of Candida auris outbreak in a tertiary-care setting in Saudi Arabia |
| Q89426621 | Mcr colistin resistance gene: a systematic review of current diagnostics and detection methods |
| Q64359214 | New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): Focus on environmental survival and germicide susceptibility |
| Q94464436 | Nine Things Genomics Can Tell Us About Candida auris |
| Q92071802 | Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris |
| Q64070550 | The global challenge of Candida auris in the intensive care unit |
Search more.